Tufts, Lowell General deal not likely to drive up costs, state panel says

The Massachusetts Health Policy Commission has decided not to perform a detailed analysis of a proposed transaction between Tufts Medical Center in Boston and Lowell (Mass.) General Hospital because the deal is unlikely to increase healthcare costs, according to a report from The Boston Globe.

Advertisement

In fact, David Seltz, the commission’s executive director, has said the transaction could actually drive costs down by causing more patients to go to Tufts instead of pricier academic medical centers in Boston, according to the report.

In April, Tufts and Lowell General announced their intent to create a new regional health system focused on population health management and other value-based care efforts. The two organizations plan to form a new parent company, although Tufts, Lowell General and their physician groups would maintain local governance.

 Now that the Health Policy Commission has decided not to study the transaction in-depth, Tufts and Lowell expect to complete the final necessary steps to form the new system soon, although they haven’t specified an expected date for the deal’s closure, according to the report.

More articles on hospital transactions:
Centura Health, Logan County Hospital sign affiliation agreement
Stanford Health Care, ValleyCare sign affiliation agreement
4 recent hospital transactions and partnerships 

 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Transactions & Valuation Issues

Advertisement

Comments are closed.